Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014
Filters: Author is McCune, Jeannine S [Clear All Filters]
Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.. The Journal of clinical investigation. 120(7):2345-54.. 2010.
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 72(3):607-18.. 2013.
Recipient Pretransplant Inosine Monophosphate Dehydrogenase Activity In Nonmyeloablative Hct.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2014.
Aprepitant pharmacokinetics and assessing the impact of aprepitant on cyclophosphamide metabolism in cancer patients undergoing hematopoietic stem cell transplantation.. Journal of clinical pharmacology. 52(4):586-94.. 2012.
Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.. Pediatric blood & cancer.. 2013.
Predictive Performance of a Physiologically Based Pharmacokinetic Model of Busulfan in Children.. Pediatric hematology and oncology.. 2014.
Population pharmacokinetics of intravenous busulfan in children: revised body weight-dependent NONMEM® model to optimize dosing.. European journal of clinical pharmacology.. 2014.
Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.. Cancer chemotherapy and pharmacology. 72(5):991-1000.. 2013.
Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.. Transplantation. 88(3):317-22.. 2009.
Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human Hepatocytes.. Scientia pharmaceutica. 78(3):473-481.. 2010.
High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients.. International journal of clinical pharmacology and therapeutics.. 2013.
Pharmacokinetic and Pharmacodynamic Analysis of Inosine Monophosphate Dehydrogenase (Impdh) Activity in Mmf-Treated Hct Recipients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2014.
A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.. Journal of clinical pharmacology. 52(11):1654-64.. 2012.
A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 69(1):263-272.. 2012.
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22.. 2009.
Busulfan in infants to adult hematopoietic cell transplant recipients: A population pharmacokinetic model for initial and Bayesian dose personalization.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2013.
Busulfan in hematopoietic stem cell transplant setting.. Expert opinion on drug metabolism & toxicology. 5(8):957-69.. 2009.
Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.. Journal of clinical pharmacology. 53(3):264-75.. 2013.
Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2013.
Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation: in vitro and in vivo investigations.. Drug metabolism and disposition: the biological fate of chemicals. 40(1):54-63.. 2012.
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86.. 2010.
Patterns of blood product use among patients with myelodysplastic syndrome.. Vox sanguinis. 102(4):331-337.. 2012.
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(7):1033-9.. 2013.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Information for Grant Writers
- Arnold Library News
- Affiliations and Memberships
- Journals List
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog
- Document Delivery Form
- Center-Authored Papers
- Institutional Repository
- Researcher Profiles